We re still a way from being able to fully manage type 1 diabetes autonomously, but four major new studies into artificial pancreas technologies could help.
The National Institutes of Health NIH has announced that it is funding four new clinical trials designed to test out artificial pancreas systems — to the tune of a whopping $41 million in government grants.
The hope is to move closed-loop artificial pancreas systems closer to receiving the necessary regulatory approval.
The large-scale studies, which will involve hundreds of people, will take place later this year and into 2018.
Participants will be able to self-monitor for the study, and can live at home as usual while taking part.
The research is related to type 1 diabetes, which is the condition in which the pancreas stops producing insulin, Dr. Roman Hovorka of University of Cambridge Metabolic Research Laboratories, who is heading up one of the trials, told Digital Trends.